BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20528205)

  • 1. Oncological repercussions of polycystic ovary syndrome.
    de França Neto AH; Rogatto S; Do Amorim MM; Tamanaha S; Aoki T; Aldrighi JM
    Gynecol Endocrinol; 2010 Oct; 26(10):708-11. PubMed ID: 20528205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystic ovary syndrome and cancer.
    Balen A
    Hum Reprod Update; 2001; 7(6):522-5. PubMed ID: 11727859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycystic ovary syndrome and the postmenopausal woman.
    Ireland K; Child T
    J Br Menopause Soc; 2006 Dec; 12(4):143-8. PubMed ID: 17178014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Polycystic ovary syndrome associated neoplasms].
    Spritzer PM; Morsch DM; Wiltgen D
    Arq Bras Endocrinol Metabol; 2005 Oct; 49(5):805-10. PubMed ID: 16444364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The polycystic ovary syndrome and gynecological cancer risk.
    Meczekalski B; Pérez-Roncero GR; López-Baena MT; Chedraui P; Pérez-López FR
    Gynecol Endocrinol; 2020 Apr; 36(4):289-293. PubMed ID: 32103691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis.
    Barry JA; Azizia MM; Hardiman PJ
    Hum Reprod Update; 2014; 20(5):748-58. PubMed ID: 24688118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycystic ovary syndrome and gynecological cancers: is there a link?
    Gadducci A; Gargini A; Palla E; Fanucchi A; Genazzani AR
    Gynecol Endocrinol; 2005 Apr; 20(4):200-8. PubMed ID: 16019362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrium in PCOS: Implantation and predisposition to endocrine CA.
    Giudice LC
    Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):235-44. PubMed ID: 16772154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of IGF I in gynecology and obstetrics].
    Bettahar-Lebugle K; Ohl J; Moreau L; Dellenbach P
    Contracept Fertil Sex; 1995 May; 23(5):302-6. PubMed ID: 7613575
    [No Abstract]   [Full Text] [Related]  

  • 10. Is polycystic ovary syndrome, a state of relative estrogen excess, a real risk factor for estrogen-dependant malignancies?
    Fanta M
    Gynecol Endocrinol; 2013 Feb; 29(2):145-7. PubMed ID: 23127146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial adenocarcinoma and polycystic ovary syndrome: risk factors, management, and prognosis.
    Elliott JL; Hosford SL; Demopoulos RI; Perloe M; Sills ES
    South Med J; 2001 May; 94(5):529-31. PubMed ID: 11372809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer risk and PCOS.
    Dumesic DA; Lobo RA
    Steroids; 2013 Aug; 78(8):782-5. PubMed ID: 23624028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycystic ovary syndrome increases the risk of endometrial cancer in women aged less than 50 years: an Australian case-control study.
    Fearnley EJ; Marquart L; Spurdle AB; Weinstein P; Webb PM;
    Cancer Causes Control; 2010 Dec; 21(12):2303-8. PubMed ID: 20953904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anovulation with or without PCO, hyperandrogenaemia and hyperinsulinaemia as promoters of endometrial and breast cancer.
    Papaioannou S; Tzafettas J
    Best Pract Res Clin Obstet Gynaecol; 2010 Feb; 24(1):19-27. PubMed ID: 19264556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystic ovary syndrome and endometrial cancer.
    Navaratnarajah R; Pillay OC; Hardiman P
    Semin Reprod Med; 2008 Jan; 26(1):62-71. PubMed ID: 18181084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic ovary syndrome and the risk of endometrial, ovarian and breast cancer: An updated meta-analysis.
    Li Z; Wang YH; Wang LL; Hu DT; Teng Y; Zhang TY; Yan ZY; Wang F; Zou YF
    Scott Med J; 2022 Aug; 67(3):109-120. PubMed ID: 35686317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications.
    Diamanti-Kandarakis E
    Expert Rev Mol Med; 2008 Jan; 10():e3. PubMed ID: 18230193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
    Barber TM; Wass JA; McCarthy MI; Franks S
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Peculiar relationships between endometrial carcinoma and body in young women].
    Vishnevskaia EE
    Vopr Onkol; 2004; 50(4):440-3. PubMed ID: 15605768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial adenocarcinoma in a young woman.
    Caserta D; Bordi G; Scarani S; Moscarini M
    Eur J Gynaecol Oncol; 2013; 34(2):179-82. PubMed ID: 23781594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.